Knowledge and Attitude Among Healthcare Workers Towards Malaria Vaccine, Sudan 2025.

September 18, 2025 updated by: Research and Publication office
This study assesses Sudanese healthcare workers' knowledge and attitudes toward the malaria vaccine in 2025, considering demographic and professional factors. It examines awareness of malaria prevalence, WHO recommendations, vaccine type, efficacy, and safety, along with confidence in recommending it and its acceptability. The findings will aid in designing interventions to improve vaccine uptake and reduce malaria burden.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

This study aims to assess the knowledge and attitudes of Sudanese healthcare workers (HCWs) toward the malaria vaccine in 2025. It examines how demographic factors and professional roles influence their understanding and perception. The knowledge assessment includes awareness of malaria prevalence, WHO vaccine recommendations, and vaccine type, efficacy, and safety. The attitude evaluation focuses on confidence in recommending the vaccine and perceptions of its feasibility and acceptance in Sudan. The findings will help design targeted interventions to enhance vaccine uptake and reduce the malaria burden.

Study Type

Observational

Enrollment (Actual)

222

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Sudan
    • Khartoum State
      • Khartoum, Khartoum State, Sudan, 11111
        • Research and publication office

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

Study Population Description:

The study will include healthcare workers (doctors, nurses, pharmacists, and public health staff) from various healthcare facilities in Sudan.

Description

Inclusion criteria:

  • Graduates of healthcare profession fields with at least one year of healthcare practice following graduation.
  • Voluntary agreement and written informed consent. exclusion criteria: non medical graduates

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Knowledge regarding malaria vaccine
Time Frame: Jan - Apr 2025
Included 11 questions about awareness, malaria and malaria vaccination
Jan - Apr 2025
Attitude regarding malaria vaccine
Time Frame: Jan - Apr 2025
5 point likert-scale assessment
Jan - Apr 2025

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Research and Publication office

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 16, 2025

Primary Completion (Actual)

April 23, 2025

Study Completion (Actual)

April 23, 2025

Study Registration Dates

First Submitted

February 9, 2025

First Submitted That Met QC Criteria

September 18, 2025

First Posted (Estimated)

September 26, 2025

Study Record Updates

Last Update Posted (Estimated)

September 26, 2025

Last Update Submitted That Met QC Criteria

September 18, 2025

Last Verified

January 1, 2025

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 24008

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Malaria

Clinical Trials on No interventions

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Jamaica

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe